Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U5A small nuclear 3, pseudogene (RNU5A-3P)
- Target
- RNU5A-3P
- Molecular classification
- Other, Small nuclear RNA pseudogene
01
Overview
RNA, U5A small nuclear 3, pseudogene (RNU5A-3P) is a human **small nuclear RNA pseudogene** on chromosome 8[4]. It is a non-coding derivative of the U5 snRNA family, which is essential for the splicing of pre-mRNA in eukaryotic cells when functional. The U5 snRNA itself is part of the major spliceosome complex and is involved in the alignment of exons during mRNA maturation, but pseudogenes such as RNU5A-3P are presumed non-functional and lack evidence for involvement in cellular processes or disease[4][2][5][3]. There are no known drugs, biomarkers, or therapeutic strategies targeting RNU5A-3P, and it does not play a role in human disease or serve as a therapeutic target.
- Other names
- RNU5A-3PRNA, U5A small nuclear 3, pseudogene
02
Mechanism of action
None (no mechanism of action because it is not a therapeutic target)
03
Biological functions
None established (pseudogenes are typically nonfunctional; functional U5 snRNAs are involved in splicing, but pseudogenes are not[2][3][7][4])
04
Disease associations
None established (no direct connection to diseases given its pseudogene status; pathogenic roles are ascribed to functional snRNA genes in neurodevelopmental disorders, not to pseudogenes[5][4]. Rare cases of snRNA pseudogene functionality are experimental and not applicable here.)
05
Safety considerations
None (as a non-functional pseudogene, it poses no specific safety or therapeutic challenges)
06
Interacting drugs
None (no drugs target snRNA pseudogenes such as RNU5A-3P[4][5])
07
Biomarkers
None (there are no current diagnostic or predictive biomarkers associated with RNU5A-3P)
Beyond the preview
Go deeper on RNA, U5A small nuclear 3, pseudogene (RNU5A-3P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U5A small nuclear 3, pseudogene (RNU5A-3P).